The clinical and economic outcomes of whole genome sequencing availability
- n containing a hospital outbreak of
The clinical and economic outcomes of whole genome sequencing - - PowerPoint PPT Presentation
The clinical and economic outcomes of whole genome sequencing availability on containing a hospital outbreak of resistant Escherichia coli Presented by Thomas Elliott 16 October 2019 Acknowledgments PA Hospital Infection Control Team Other
QIMR Berghofer Dr Louisa Gordon, A. Prof Astrid Rodriguez-Acevedo, SRO AusHSI Xing Lee, SRO Prof Nicholas Graves, PA Hospital Infection Control Team Patrick Harris, Microbiologist Joel Douglas, Chief Scientist Catherine Watson, Clinical Nurse Consultant Belinda Henderson, Clinical Nurse Consultant Other Collaborators Prof Deborah S. Schofield Prof David L. Paterson
MLPA
Multiplex Ligation-dependent Probe Amplification
30+ days No pathogen of interest
– discrete event simulation
– agent based model
determine how these entities learn, adapt and interact with each other
– Geographical Information System
a) Socio-economic variables b) Episode of care variables:
c) Other information:
Y/N flag for patients which were colonised with Oxa-181 Extracted data on:
and 1 August 2017
the hospital on 1 April 2017
Initial ward locations & Ward transfers – estimated empirically from the QHAPDC data set Ward length of stay – estimated as independent Gamma distributions for all
combinations using the methods of moments
Ward transfer pairing Number proportion ward stay, days (SD) from to BANK discharged 126 0.82 22.6 (25.8) BANK
24 0.16 3.7 (3.9) BANK W2D 3 0.02 2.3 (0.6) BUNY discharged 101 0.83 25.8 (29.1) BUNY
17 0.14 7.9 (15.3) BUNY W2C 4 0.03 17.5 (29)
Transmission formula:
# colonised = Binomial(Prob, #Susc)
– Sample preparation, $15 – Sequencing, $105 – Analysis/storage, $18 – Scientist, $103 – Isolate handling, $5 – Labour admin, $33 – Bioinformatics, $76
– Hospital cleaning staff labour hourly rate, $31 – Curtains, $33 – Consumables, $5
meeting - $462.03 – 3 senior consultants, $215 – Infection control nurse, $59 – Senior administrator, $65 – Manager, $46
– No WGS
– WGS (late)
– WGS (early)
Real-life Scenario Ideal Scenario Most Hospitals
Total number of: No WGS
Early WGS Colonized patients (SD) 352 (170) 197 3 (0) Detected patients (SD) 152 (75) 75 1 (0) WGS tests (SD) 79 2 (0) Bed closures (SD) 902 (486) 419 11 (2) Total costs $AU (SD) 766,921 (338,351) 460,137 (12,138) 65,374 (4,556)
$0 $200,000 $400,000 $600,000 $800,000 $1,000,000 $1,200,000 $1,400,000
Whole Genome Seq. costs Infection Control Executive Meetings Microbiology test costs Cleaning costs Nursing costs Bed Closure costs Cost of bed closure increased to $800